GDUFA Research Outcomes
PBPK Models
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to physiologically-based pharmacokinetics (PBPK) computational modeling to support generic product development and assessment.
-
A Multiscale Framework For Computational Inhalation Pharmacology
Kannan, Ravi; Chen, Z J; Singh, Narendra; Przekwas, Andrzekj; Delvadia, Renishkumar; Tian, Geng
-
Prediction of Respimat® Inhaler Spray: Co-Flow Air Behavior
Kakhi, Maziar
-
PBPK Models: Opportunities for Enhancements
Jusko, William
-
Overview of Complex Generics Regulatory Perspective on Bioequivalence
Jiang, Jeff
-
PBPK Modeling to Support Risk Assessment for Oral Drug Products, Including Waiver of Fed BE Studies
Jereb, Rebeka
-
PBPK Modeling for Different Locally-Administered Drug Products
Jereb, Rebeka
-
Establishing Bioequivalence Using Characterization Based Approaches for Topical Products – Challenges & Solutions
Jani, Romit
-
Predictive Performance of PBPK Dose Estimates for Pediatric Trials
Dallmann, Andre
-
Use of PBPK in New Drug Development and Regulatory Review – Clinical Pharmacology Perspective
Huang, Shiew-Mei
-
Correlating The In Vitro Dissolution Behavior Of Inhalation And Nasal Drug Products With In Vivo Performance: Pitfalls And Potential Solutions Using The Transwell System
Hochhaus, Guenther